On December 2, 2024, H. Lundbeck A/S announced the successful completion of the previously announced transaction to acquire all of the outstanding shares of Longboard Pharmaceuticals, Inc. With the completion of the acquisition, Longboard is now a wholly owned subsidiary of Lundbeck.
To learn more about Lundbeck and the transaction, please visit the Lundbeck website.